These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. UNC93B1 variants underlie TLR7-dependent autoimmunity. Wolf C; Lim EL; Mokhtari M; Kind B; Odainic A; Lara-Villacanas E; Koss S; Mages S; Menzel K; Engel K; Dückers G; Bernbeck B; Schneider DT; Siepermann K; Niehues T; Goetzke CC; Durek P; Minden K; Dörner T; Stittrich A; Szelinski F; Guerra GM; Massoud M; Bieringer M; de Oliveira Mann CC; Beltrán E; Kallinich T; Mashreghi MF; Schmidt SV; Latz E; Klughammer J; Majer O; Lee-Kirsch MA Sci Immunol; 2024 Feb; 9(92):eadi9769. PubMed ID: 38207055 [TBL] [Abstract][Full Text] [Related]
4. Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus. Kiener S; Ribi C; Keller I; Chizzolini C; Trendelenburg M; Huynh-Do U; von Kempis J; On Behalf Of Swiss Sle Cohort Study Sscs ; Leeb T Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440442 [TBL] [Abstract][Full Text] [Related]
5. Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. David C; Arango-Franco CA; Badonyi M; Fouchet J; Rice GI; Didry-Barca B; Maisonneuve L; Seabra L; Kechiche R; Masson C; Cobat A; Abel L; Talouarn E; Béziat V; Deswarte C; Livingstone K; Paul C; Malik G; Ross A; Adam J; Walsh J; Kumar S; Bonnet D; Bodemer C; Bader-Meunier B; Marsh JA; Casanova JL; Crow YJ; Manoury B; Frémond ML; Bohlen J; Lepelley A J Exp Med; 2024 Aug; 221(8):. PubMed ID: 38869500 [TBL] [Abstract][Full Text] [Related]
6. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. Fukui R; Saitoh S; Matsumoto F; Kozuka-Hata H; Oyama M; Tabeta K; Beutler B; Miyake K J Exp Med; 2009 Jun; 206(6):1339-50. PubMed ID: 19451267 [TBL] [Abstract][Full Text] [Related]
7. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Fukui R; Saitoh S; Kanno A; Onji M; Shibata T; Ito A; Onji M; Matsumoto M; Akira S; Yoshida N; Miyake K Immunity; 2011 Jul; 35(1):69-81. PubMed ID: 21683627 [TBL] [Abstract][Full Text] [Related]
14. A Missense Variant Affecting the C-Terminal Tail of UNC93B1 in Dogs with Exfoliative Cutaneous Lupus Erythematosus (ECLE). Leeb T; Leuthard F; Jagannathan V; Kiener S; Letko A; Roosje P; Welle MM; Gailbreath KL; Cannon A; Linek M; Banovic F; Olivry T; White SD; Batcher K; Bannasch D; Minor KM; Mickelson JR; Hytönen MK; Lohi H; Mauldin EA; Casal ML Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32028618 [TBL] [Abstract][Full Text] [Related]
15. RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features. Elloumi N; Fakhfakh R; Abida O; Hachicha H; Marzouk S; Fourati M; Bahloul Z; Masmoudi H Int J Immunogenet; 2021 Jun; 48(3):250-259. PubMed ID: 33650302 [TBL] [Abstract][Full Text] [Related]
16. TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals. Satterthwaite AB Curr Rheumatol Rep; 2021 Nov; 23(11):80. PubMed ID: 34817709 [TBL] [Abstract][Full Text] [Related]
17. N-glycosylation of UNC93B1 at a Specific Asparagine Residue Is Required for TLR9 Signaling. Song HS; Park S; Huh JW; Lee YR; Jung DJ; Yang C; Kim SH; Kim HM; Kim YM Front Immunol; 2022; 13():875083. PubMed ID: 35874766 [TBL] [Abstract][Full Text] [Related]